HCW-9218
- Generic Name
- HCW-9218
HCW9218 in Select Advanced Solid Tumors
- First Posted Date
- 2022-04-11
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 18
- Registration Number
- NCT05322408
- Locations
- 🇺🇸
Masonic Cancer Center - University of Minnesota, Minneapolis, Minnesota, United States
HCW9218 for Advanced Pancreatic Cancer
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- ImmunityBio, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT05304936
- Locations
- 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
🇺🇸HonorHealth, Scottsdale, Arizona, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
Antitumor Activity of Neoadjuvant Chemotherapy with or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer
Phase 2
Withdrawn
- Conditions
- Ovarian Cancer
- Interventions
- First Posted Date
- 2021-12-06
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- Haider Mahdi
- Target Recruit Count
- 33
- Registration Number
- NCT05145569
- Locations
- 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath